Molecular genetic advances in neurodegenerative disorders.Clin Lab Med. 1995 Dec; 15(4):915-26.CL
Abstract
Advances in molecular genetics have had a major impact on our understanding of the pathogenesis of neurologic disorders. This article discusses molecular genetic contributions to our knowledge of Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease, as well as their implications for diagnosis and treatment. Specific, sensitive testing for Huntington's disease is now possible; elucidation of the pathogenesis of familial amyotrophic lateral sclerosis has been achieved and has launched promising drug trials; and the heterogeneity and pathogenetic complexity of Alzheimer's disease have been revealed.
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
8838230
Citation
Aguilera, A J.. "Molecular Genetic Advances in Neurodegenerative Disorders." Clinics in Laboratory Medicine, vol. 15, no. 4, 1995, pp. 915-26.
Aguilera AJ. Molecular genetic advances in neurodegenerative disorders. Clin Lab Med. 1995;15(4):915-26.
Aguilera, A. J. (1995). Molecular genetic advances in neurodegenerative disorders. Clinics in Laboratory Medicine, 15(4), 915-26.
Aguilera AJ. Molecular Genetic Advances in Neurodegenerative Disorders. Clin Lab Med. 1995;15(4):915-26. PubMed PMID: 8838230.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Molecular genetic advances in neurodegenerative disorders.
A1 - Aguilera,A J,
PY - 1995/12/1/pubmed
PY - 1995/12/1/medline
PY - 1995/12/1/entrez
SP - 915
EP - 26
JF - Clinics in laboratory medicine
JO - Clin Lab Med
VL - 15
IS - 4
N2 - Advances in molecular genetics have had a major impact on our understanding of the pathogenesis of neurologic disorders. This article discusses molecular genetic contributions to our knowledge of Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease, as well as their implications for diagnosis and treatment. Specific, sensitive testing for Huntington's disease is now possible; elucidation of the pathogenesis of familial amyotrophic lateral sclerosis has been achieved and has launched promising drug trials; and the heterogeneity and pathogenetic complexity of Alzheimer's disease have been revealed.
SN - 0272-2712
UR - https://www.unboundmedicine.com/medline/citation/8838230/Molecular_genetic_advances_in_neurodegenerative_disorders_
DB - PRIME
DP - Unbound Medicine
ER -